Subscribe to RSS
DOI: 10.1055/s-0044-1787820
The Influence of Genetics and Gene Polymorphism on Biological Complications for Dental Implant Survival: A Review
Abstract
The objective of this review is to expose the main genetic changes and genetic polymorphisms that may or may not be associated with greater susceptibility to reduced survival of dental implants and, consequently, to their loss. Case–control studies that fully portrayed the specific types of genetic polymorphisms that may be associated with dental implant failure were included by searching in the PubMed, Scopus, and Web of Science databases from 2010 to 2023. The following descriptors and their combinations in English were used to search for articles: “dental implants,” “bone genes,” “genetics,” “polymorphism genetics,” “genetic risk factor,” and “interleukin.” The initial search resulted in 107 results (PubMed n = 47, Scopus n = 14, and Web of Science n = 46). After a manual search, reviewing each article's title and abstract, and excluding duplicates, systematic reviews, and literature reviews, 30 articles were selected. After reading these 30 articles in full, 18 studies that did not describe the specific genetic polymorphism in relation to dental implant survival were excluded. Therefore, 12 articles were included in this review. The genetic polymorphisms of interleukin (IL)-1A, IL-1B, IL-4, IL-6, IL-10, IL-1 receptor antagonist, tumor necrosis factor-α, receptor activator of nuclear factor kappa B legend, and cluster of differentiation 14 were analyzed in the included studies. In seven of the studies, a statistically significant correlation between genetic polymorphisms and dental implant failure was observed. Of the polymorphisms studied, IL-1A (−899), IL-1B (+3954), and IL-4 (+33) showed a greater association with dental implant loss.
Publication History
Article published online:
16 July 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Pigossi SC, Alvim-Pereira F, Montes CC. et al. Genetic association study between interleukin 10 gene and dental implant loss. Arch Oral Biol 2012; 57 (09) 1256-1263
- 2 Vaz P, Gallas MM, Braga AC, Sampaio-Fernandes JC, Felino A, Tavares P. IL1 gene polymorphisms and unsuccessful dental implants. Clin Oral Implants Res 2012; 23 (12) 1404-1413
- 3 Sampaio Fernandes M, Vaz P, Braga AC, Sampaio Fernandes JC, Figueiral MH. The role of IL-1 gene polymorphisms (IL1A, IL1B, and IL1RN) as a risk factor in unsuccessful implants retaining overdentures. J Prosthodont Res 2017; 61 (04) 439-449
- 4 Dirschnabel AJ, Alvim-Pereira F, Alvim-Pereira CC, Bernardino JF, Rosa EA, Trevilatto PC. Analysis of the association of IL1B(C-511T) polymorphism with dental implant loss and the clusterization phenomenon. Clin Oral Implants Res 2011; 22 (11) 1235-1241
- 5 Cosyn J, Christiaens V, Koningsveld V. et al. An exploratory case-control study on the impact of IL-1 gene polymorphisms on early implant failure. Clin Implant Dent Relat Res 2016; 18 (02) 234-240
- 6 Melo RF, Lopes BM, Shibli JA, Marcantonio Jr E, Marcantonio RA, Galli GM. Interleukin-1β and interleukin-6 expression and gene polymorphisms in subjects with peri-implant disease. Clin Implant Dent Relat Res 2012; 14 (06) 905-914
- 7 Petkovic-Curcin A, Zeljic K, Cikota-Aleksic B, Dakovic D, Tatic Z, Magic Z. Association of cytokine gene polymorphism with peri-implantitis risk. Int J Oral Maxillofac Implants 2017; 32 (05) e241-e248
- 8 Ribeiro R, Melo R, Tortamano Neto P, Vajgel A, Souza PR, Cimões R. Polymorphisms of Il-10 (-1082) and RANKL (-438). Int J Dent 2017; 2017: 3901368
- 9 He K, Jian F, He T, Tang H, Huang B, Wei N. Analysis of the association of TNF-α, IL-1A, and IL-1B polymorphisms with peri-implantitis in a Chinese non-smoking population. Clin Oral Investig 2020; 24 (02) 693-699
- 10 Pigossi SC, Alvim-Pereira F, Alvim-Pereira CC, Trevilatto PC, Scarel-Caminaga RM. Association of interleukin 4 gene polymorphisms with dental implant loss. Implant Dent 2014; 23 (06) 723-731
- 11 Hamdy AA, Ebrahem MA. The effect of interleukin-1 allele 2 genotype (IL-1a(-889) and IL-1b(+3954)) on the individual's susceptibility to peri-implantitis: case-control study. J Oral Implantol 2011; 37 (03) 325-334
- 12 Gurol C, Kazazoglu E, Dabakoglu B, Korachi M. A comparative study of the role of cytokine polymorphisms interleukin-10 and tumor necrosis factor alpha in susceptibility to implant failure and chronic periodontitis. Int J Oral Maxillofac Implants 2011; 26 (05) 955-960
- 13 Karoussis IK, Kotsovilis S, Fourmousis I. A comprehensive and critical review of dental implant prognosis in periodontally compromised partially edentulous patients. Clin Oral Implants Res 2007; 18 (06) 669-679
- 14 Montes CC, Alvim-Pereira F, de Castilhos BB, Sakurai ML, Olandoski M, Trevilatto PC. Analysis of the association of IL1B (C+3954T) and IL1RN (intron 2) polymorphisms with dental implant loss in a Brazilian population. Clin Oral Implants Res 2009; 20 (02) 208-217
- 15 Campos MI, Godoy dos Santos MC, Trevilatto PC, Scarel-Caminaga RM, Bezerra FJ, Line SR. Interleukin-2 and interleukin-6 gene promoter polymorphisms, and early failure of dental implants. Implant Dent 2005; 14 (04) 391-396
- 16 Wright HL, McCarthy HS, Middleton J, Marshall MJ. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med 2009; 2 (01) 56-64
- 17 Loos B, van der Velden U, Laine ML. Susceptibility. In: Lindhe J, Lang NP, Karring T. eds. Clinical Periodontology and Implant Dentistry. 5th ed.. Oxford, UK: Blackwell Munksgaard; 2008: 329-330
- 18 Tew JG, Kosco MH, Szakal AK. The alternative antigen pathway. Immunol Today 1989; 10 (07) 229-232
- 19 Pociot F, Mølvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22 (06) 396-402
- 20 Kornman KS. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 1999; 28 (03) 520-526
- 21 Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002; 13 (04) 349-358
- 22 Nowzari H, Yi K, Chee W, Rich SK. Immunology, microbiology, and virology following placement of NobelPerfect scalloped dental implants: analysis of a case series. Clin Implant Dent Relat Res 2008; 10 (03) 157-165
- 23 Duarte PM, de Mendonça AC, Máximo MB, Santos VR, Bastos MF, Nociti Júnior FH. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res 2009; 20 (05) 514-520